:: Library Catalog

Copertina

Salvato in:

Dettagli Bibliografici
Autore principale:	Durník, Robin
Natura:	Recurso digital
Lingua:
Pubblicazione:	Zenodo 2025
Accesso online:	https://doi.org/10.5281/zenodo.16533283
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

List of chemicals from TG-GATEs
di: Durník, Robin
Pubblicazione: (2025)

List of chemicals from ECHA REACH
di: Durník, Robin
Pubblicazione: (2025)

Democratizing Drug Discovery: A Scalable Open-Source Pipeline for Massive Multi-Target QSAR Modeling Using ChEMBL36
di: Zaliani, Andrea, et al.
Pubblicazione: (2026)

Single-Cell Transcriptomic Identification of Drug Repurposing Candidates for Ankylosing Spondylitis via PBMC scRNA-seq and ChEMBL Target Screening
di: Ritschel, Glen Charles, et al.
Pubblicazione: (2026)

Biological Data Resources at the EMBL-EBI
di: Rodrigo Lopez
Pubblicazione: (2008)

FDA approves first immunotherapy drug for nasopharyngeal carcinoma
di: Mary Beth Nierengarten
Pubblicazione: (2024)

Critical insights into the evolving drug‐approval process in China
di: Mina Nikanjam, et al.
Pubblicazione: (2024)

FDA‐approved drugs featuring macrocycles or medium‐sized rings
di: Youlong Du, et al.
Pubblicazione: (2025)

Diffuse midline gliomas get first FDA‐approved drug
di: Leah Lawrence
Pubblicazione: (2025)

Legal analysis assails FDA's lowering of standards for drug approval
Pubblicazione: (2026)

Discrepancy in accelerated approvals for cancer drugs in the United States and Europe
di: Mary Beth Nierengarten
Pubblicazione: (2024)

FDA approves drug to treat neurologic manifestations of Hunter syndrome
Pubblicazione: (2026)

Do drugs approved via expedited approval pathways have therapeutic advantages? A systematic review and meta‐analysis
di: Ashleigh Hooimeyer, et al.
Pubblicazione: (2026)

Identification of aryl hydrocarbon receptor allosteric antagonists from clinically approved drugs
di: Farag E. S. Mosa, et al.
Pubblicazione: (2024)

The mechanism of action and chemical synthesis of FDA newly approved drug molecules
di: Dan‐Dan Shen, et al.
Pubblicazione: (2024)

Deployment and transcriptional evaluation of nitisinone, an FDA ‐approved drug, to control bed bugs
di: Marcos Sterkel, et al.
Pubblicazione: (2025)

Novel drugs approved by the EMA, the FDA and the MHRA in 2024: A year in review
di: Stavros Topouzis, et al.
Pubblicazione: (2025)

In vitro effectivity of three approved drugs and their synergistic interaction against Leishmania infantum
di: Iman Fathy Abou-El-Naga
Pubblicazione: (2020)

Postmarket safety communications on drugs approved in Japan: A 25‐year analysis
di: Yusuke Tanaka, et al.
Pubblicazione: (2024)

Off-label use of psychotropic drugs beyond officially approved indications in Colombia
di: Paola Marcela Fletscher-Covaleda
Pubblicazione: (2017)

In vitro and in silico investigation of FDA‐approved drugs to be repurposed against Alzheimer's disease
di: Didem Akkaya, et al.
Pubblicazione: (2024)

Study of trofinetide in Rett syndrome: Lessons from an approved drug for a severe neurodevelopmental disorder
di: Walter E. Kaufmann
Pubblicazione: (2025)

2024 leucovorin paper retracted, drug pending FDA approval for cerebral folate deficiency
di: Alison Knopf
Pubblicazione: (2026)

The demolition drug
di: Orwant, Robin
Pubblicazione: (1998)

Inside Back Cover: Flexibility‐Aided Orientational Self‐Sorting and Transformations of Bioactive Homochiral Cuboctahedron Pd 12 L 16 (Angew. Chem. Int. Ed. 37/2025)
di: Subhasis Chattopadhyay, et al.
Pubblicazione: (2025)

Cryptosporidiosis vaccine approved
di: Abby Webb
Pubblicazione: (2024)

Policy position approved
Pubblicazione: (2026)

Identification, validation, and characterization of approved and investigational drugs interfering with the SARS‐CoV‐2 endoribonuclease Nsp15
di: Spyros D. Chatziefthymiou, et al.
Pubblicazione: (2025)

Status of oncology drugs with a conditional approval: A cross‐sectional comparison of the Food and Drug Administration and Health Canada
di: Joel Lexchin
Pubblicazione: (2025)

FDA approves second‐line TROP2‐directed antibody–drug conjugate Dato‐DXd for EGFR ‐mutated NSCLC
di: Leah Lawrence
Pubblicazione: (2025)

The US Food and Drug administration has approved resmetirom as the first drug to treat metabolic dysfunction‐associated steatohepatitis (MASH)
di: Iskandar Idris
Pubblicazione: (2024)

Raw data with Ethical approval
di: Choukaife, Hazem
Pubblicazione: (2025)

Swedish farmers' approval of nudges
di: Liesbeth Colen, et al.
Pubblicazione: (2024)

State attachment and gubernatorial approval
di: Jonathan Winburn, et al.
Pubblicazione: (2024)

Barriers and hurdles delaying governance approval for an ethically approved nationwide clinical trial in pancreatic cancer
di: Ariadna Recasens, et al.
Pubblicazione: (2024)

Reshaping study design for faster extrapolation‐based drug approval in pediatric inflammatory bowel diseases: An ESPGHAN–NASPGHAN position paper
di: Dan Turner, et al.
Pubblicazione: (2025)

Repurposing FDA‐approved drugs to target malaria through inhibition of dihydrofolate reductase in the folate biosynthesis pathway: A prospective approach
di: Kanika Verma, et al.
Pubblicazione: (2024)

Facing the challenge of the desk review approval
di: Maria Sylvia Macchione Saes
Pubblicazione: (2018)

Accelerated approval of multiple myeloma therapies
di: Mary Beth Nierengarten
Pubblicazione: (2024)

Iraqi voters approve new Constitution
Pubblicazione: (2005)